-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Bolt Biotherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2024.
- Bolt Biotherapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 38.2M shares, a 0.98% increase year-over-year.
- Bolt Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 38.2M shares, a 0.98% increase from 2023.
- Bolt Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 37.8M shares, a 1.21% increase from 2022.
- Bolt Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 37.4M shares, a 12.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)